These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6862148

  • 1. Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432.
    Abe S, Takahashi K, Tsubouchi J, Yamazaki M, Mizuno D.
    Gan; 1983 Apr; 74(2):273-8. PubMed ID: 6862148
    [Abstract] [Full Text] [Related]

  • 2. Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
    Abe S, Takahashi K, Yamazaki M, Mizuno D.
    Jpn J Cancer Res; 1985 Jul; 76(7):626-30. PubMed ID: 3928559
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
    Abe S, Tsubouchi J, Takahashi K, Yamazaki M, Mizuno D.
    Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585
    [Abstract] [Full Text] [Related]

  • 4. Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction.
    Masuko Y, Nakajima H, Tsubouchi J, Yamazaki M, Mizuno D, Abe S.
    Gan; 1982 Oct; 73(5):790-7. PubMed ID: 7166231
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect of bacterial lipopolysaccharide (LPS) alone and in combination with lentinan on MH-134 tumors in C3H/He mice.
    Moriya N, Miwa H, Orita K.
    Acta Med Okayama; 1984 Feb; 38(1):49-55. PubMed ID: 6702486
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
    Moriya N, Miwa H, Taketsuka S, Orita K.
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
    [Abstract] [Full Text] [Related]

  • 7. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
    Gatanaga T, Takahashi K, Yamazaki M, Mizuno D, Abe S.
    Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
    [Abstract] [Full Text] [Related]

  • 8. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
    Abe S, Yoshioka O, Masuko Y, Tsubouchi J, Kohno M, Nakajima H, Yamazaki M, Mizono D.
    Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
    [Abstract] [Full Text] [Related]

  • 9. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
    Moriyama M, Miwa H, Moriya N, Orita K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effect of polysaccharide lentinan on MH-134 ascites hepatoma in C3H/He mice.
    Moriyama M.
    Acta Med Okayama; 1982 Feb; 36(1):49-60. PubMed ID: 7064733
    [Abstract] [Full Text] [Related]

  • 11. Different local therapeutic effects of various polysaccharides on MH134 hepatoma in mice and its relation to inflammation induced by the polysaccharides.
    Abe S, Takahashi K, Tsubouchi J, Aida K, Yamazaki M, Mizuno D.
    Gan; 1984 May; 75(5):459-65. PubMed ID: 6745566
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice.
    Makidono R, Matsuura K, Makidono A.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb 25; 44(2):379-91. PubMed ID: 6477682
    [No Abstract] [Full Text] [Related]

  • 13. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H.
    Nihon Geka Gakkai Zasshi; 1984 Nov 25; 85(11):1479-89. PubMed ID: 6521727
    [Abstract] [Full Text] [Related]

  • 14. [Combination use of lentinan with X-ray therapy in a mouse experimental tumor system (Part I). Basic studies].
    Shiio T, Tsuchiya Y, Ohishi K, Yoshihama T.
    Gan To Kagaku Ryoho; 1988 Feb 25; 15(2):313-7. PubMed ID: 3341791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M.
    Nihon Geka Gakkai Zasshi; 1988 Jun 25; 89(6):880-8. PubMed ID: 2972906
    [Abstract] [Full Text] [Related]

  • 17. Enhanced tumor growth and metastatic spread of an MH134 variant lacking a part of the MM antigen: a possible role of antibody-dependent cellular cytotoxicity in control of tumor growth and metastases.
    Hara H, Kawase I, Komuta K, Masuno T, Kishimoto S.
    Int J Cancer; 1989 Jul 15; 44(1):137-42. PubMed ID: 2744883
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined effect of cyclocytidine and lentinan of spontaneous mammary tumors in mice.
    Tokuzen R, Okabe M, Nakahara LW.
    Gan; 1976 Apr 15; 67(2):327-9. PubMed ID: 964561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.